Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

10.24 -0.28 (-2.61%)

Delayed Quote Updated: 3:58 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Corvus Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 08, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

These stocks are gapping in today's session ↗

March 26, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Corvus Pharma Stock Dips On Bigger-Than-Feared Q4 Loss, But Retail’s Faith Grows Stronger ↗

March 25, 2025

Research and development expenses in the reported quarter rose by $2 million, primarily due to increased spending on the soquelitinib clinical trial for T-cell lymphoma.

Via Stocktwits

Earnings Scheduled For March 25, 2025 ↗

March 25, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

January 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 18, 2024

Via Benzinga

Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday? ↗

December 18, 2024

Corvus Pharmaceuticals shares interim Phase 1 trial data showing promising results for soquelitinib in treating moderate to severe atopic dermatitis.

Via Benzinga

Crude Oil Gains Over 1%, General Mills Shares Fall ↗

December 18, 2024

Via Benzinga

Dow Surges 150 Points, US Current Account Deficit Widens In Q3 ↗

December 18, 2024

Via Benzinga

Topics Stocks

An Overview of Corvus Pharma's Earnings ↗

November 11, 2024

Via Benzinga

Earnings Outlook For Corvus Pharma ↗

March 18, 2024

Via Benzinga

Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

December 18, 2024

Via Benzinga

US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak ↗

December 18, 2024

U.S. stock futures climbed on Wednesday as Wall Street awaits the Fed's final interest rate decision and its monetary policy forecasts for 2025.

Via Benzinga

Topics Economy Stocks

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket ↗

December 18, 2024

Via Benzinga

Stellantis, MicroStrategy, Bit Digital And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 30, 2024

Via Benzinga

Why Nio Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

September 30, 2024

Via Benzinga

Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

September 18, 2024

Via Benzinga

Topics Artificial Intelligence

Kaskela Law LLC Announces Shareholder Investigation of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) and Encourages Investors to Contact the Firm

September 17, 2024

From Kaskela Law LLC

Via Business Wire

Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday ↗

September 16, 2024

Via Benzinga

Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

August 07, 2024

Via Benzinga

The 2024 Millionaire’s Club: 3 Penny Stocks to Buy Now ↗

May 31, 2024

One of the best ways to spot opportunity in penny stocks to buy is by following insiders. Here are three to consider.

Via InvestorPlace

CRVS Stock Earnings: Corvus Pharma Misses EPS for Q1 2024 ↗

May 06, 2024

CRVS stock results show that Corvus Pharma missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 09, 2024

Via Benzinga

CRVS Stock Earnings: Corvus Pharma Misses EPS for Q4 2023 ↗

March 19, 2024

CRVS stock results show that Corvus Pharma missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For March 19, 2024 ↗

March 19, 2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 08, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.